Pfiz­er CEO says it's back to ba­sics af­ter painful 2023 for in­vestors: #JPM24

SAN FRAN­CIS­CO — Pfiz­er CEO Al­bert Bourla said the com­pa­ny has made the ma­jor cost-cut­ting moves re­quired to re­set its busi­ness, and will fo­cus on ex­e­cut­ing on op­er­a­tions and grow­ing mar­gins in 2024.

In a wide-rang­ing lunch with re­porters ahead of the com­pa­ny’s pre­sen­ta­tion at the JP Mor­gan Health­care Con­fer­ence on Mon­day, Bourla talked about Pfiz­er’s chal­leng­ing past year and the changes it’s made. That has in­clud­ed broad cuts meant to strip ex­cess costs from its Covid pe­ri­od, ex­ec­u­tive changes, and fo­cus­ing on delever­ag­ing and re­turn­ing cap­i­tal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER